Scientists at the Dana-Farber/Children's Hospital Cancer Center have developed an anti-cancer peptide that overcomes the stubborn resistance to chemotherapy and radiation often encountered in certain blood cancers when the disease recurs following initial treatment.

A hormone-depleting drug approved last year for the treatment of metastatic prostate cancer can help eliminate or nearly eliminate tumors in many patients with aggressive cancers that have yet to spread beyond the prostate.

Melanoma – the deadliest and most aggressive form of skin cancer – has long been linked to time spent in the sun.

CAMBRIDGE, Mass., May 8, 2012 /PRNewswire/ -- Eutropics Pharmaceuticals today announced that the United States Patent and Trademark Office has issued patent number 8,168,755 entitled,

QUINCY, Mass., April 24, 2012 /PRNewswire/ -- Everyone's a winner when they join the fight with participating Stop & Shop food stores throughout New Hampshire, Massachusetts, Rhode Island,